Finance

Lists
Why is NXG down 4,29%?
Dive Deeper
NXG:CVE
NexgenRx Inc
CAD 0,67
-4,29%
(-0,030) 1D
12 Nov., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NXG...
Open
CAD 0,69
High
CAD 0,69
Low
CAD 0,67
Mkt. cap
47,86 m
Avg. vol.
15,18 k
Volume
2,42 k
Dividend
2,24%
Quarterly dividend
CAD 0,00
Ex-dividend date
02 Nov. 2026
P/E ratio
22,54
52-wk high
CAD 0,75
52-wk low
CAD 0,29
EPS
CAD 0,03
Beta
0,76
Shares outstanding
71,12 m
No. of employees
20
Open
CAD 0,69
High
CAD 0,69
Low
CAD 0,67
Mkt. cap
47,86 m
Avg. vol.
15,18 k
Volume
2,42 k
Dividend
2,24%
Quarterly dividend
CAD 0,00
Ex-dividend date
02 Nov. 2026
P/E ratio
22,54
52-wk high
CAD 0,75
52-wk low
CAD 0,29
EPS
CAD 0,03
Beta
0,76
Shares outstanding
71,12 m
No. of employees
20
News stories
From web sources and news partners
About NexgenRx Inc
CEO-
Employees20
Founded2003
HeadquartersToronto, Ontario, Kanada
SectorFinancials
Industry-
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,62 m
4,42 m
5,00 m
5,16 m
Cost of goods sold
765,82 k
520,55 k
744,85 k
743,24 k
Cost of revenue
765,82 k
520,55 k
744,85 k
743,24 k
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 m
2,89 m
2,77 m
3,17 m
Operating expense
3,24 m
3,16 m
3,00 m
3,39 m
Total operating expenses
4,01 m
3,68 m
3,75 m
4,14 m
Operating income
609,09 k
734,96 k
1,25 m
1,02 m
Other non operating income
-35,66 k
-37,72 k
-37,74 k
-39,73 k
EBT including unusual items
566,92 k
533,63 k
1,21 m
970,24 k
EBT excluding unusual items
566,92 k
692,69 k
1,21 m
979,84 k
Income tax expense
-22,86 k
714,41 k
-22,86 k
-22,86 k
Effective tax rate
-4,03%
133,88%
-1,90%
-2,36%
Other operating expenses
-
-
-
-
Net income
589,78 k
-180,78 k
1,23 m
993,10 k
Net profit margin
12,78%
-4,09%
24,58%
19,24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6,50 k
-4,55 k
-5,61 k
-5,00 k
Net interest expenses
-6,50 k
-4,55 k
-5,61 k
-5,00 k
Depreciation and amortization charges
61,14 k
46,72 k
56,45 k
58,65 k
EBITDA
922,43 k
790,08 k
1,30 m
1,25 m
Gain or loss from assets sale
-
-2,33 k
-
9,60 k
Upcoming events
AI content may include mistakes. Learn more
Google-programme